Verified Nov 2026
Other
·
Copenhagen, Capital Region of Denmark
·
Since 1994
Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.
Bavarian Nordic at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1994
Headquarters
Copenhagen, Capital Region of Denmark
Industries
Automotive
Electric Vehicles
Medical
Military & Defense
Renewable Energy
Industrial Equipment
Overview
Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.
At a glance
Attribute | Detail |
|---|---|
Founded | 1994 |
Headquarters | Copenhagen, Capital Region of Denmark |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Bavarian Nordic makes
Bavarian Nordic manufactures vaccines for mpox, rabies, tick-borne encephalitis, cholera, and typhoid, with core capabilities in sterile manufacturing, lyophilization, and advanced vaccine formulations.
Latest developments
2026-11-13 — Bavarian Nordic Reports Strong Travel Health Growth in the (globenewswire.com)
2026-08-21 — Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance - BioSpace (biospace.com)
2026-03-11 — News | Bavarian Nordic (bavarian-nordic.com)
Facilities
Bavarian Nordic is headquartered in Copenhagen, Capital Region of Denmark. Public sources also reference these locations:
Kvistgaard, Denmark — bavarian-nordic.com
Bern, Switzerland — bioprocessintl.com
Company details
The company holds a market capitalization of approximately $2.24 billion and maintains strategic partnerships with the U.S. Government for biodefense applications. Bavarian Nordic was founded in 1994, has an estimated 1,000-5,000 employees, and is headquartered in Copenhagen, Capital Region of Denmark.
Frequently asked questions
What does Bavarian Nordic do?
Bavarian Nordic is a Danish biotechnology company founded in 1994 that develops, manufactures, and commercializes vaccines. Headquartered in Copenhagen with 1,000–5,000 employees and revenues estimated at $500M–$1B, the company serves medical, military-defense, and biodefense sectors. It is the sole global manufacturer of an approved mpox vaccine and operates manufacturing facilities in Denmark and Switzerland alongside research centers in Germany and the United States.
Where is Bavarian Nordic headquartered?
Bavarian Nordic is headquartered in Copenhagen, Capital Region of Denmark (89 Vester Voldgade, Copenhagen, Capital Region of Denmark, 1552).
When was Bavarian Nordic founded?
Bavarian Nordic was founded in 1994.
How big is Bavarian Nordic?
Bavarian Nordic has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
